Posterior Capsule Opacification Completed Phase 4 Trials for Brinzolamide (DB01194)

Also known as: Thickening of lens capsule / Posterior capsule fibrosis

IndicationStatusPhase
DBCOND0043201 (Posterior Capsule Opacification)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03192826Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser CapsulotomyPrevention